Patrick Schöffski, Prof Dr
Head of Department General Medical Oncology
Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven
Leuven, Vlaams-Brabant, Belgium
Roberta Sanfilippo, MD
MD
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardia, Italy
Javier Martin-Broto, MD, PhD
Fundación Jiménez Díaz University Hospital
Madrid, Madrid, Spain
Akira Kawai, MD
National Cancer Center Hospital Japan
Tokyo, Tokyo, Japan
Jayesh Desai, MBBS, FRACP
Royal Melbourne Hospital and Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Patricia LoRusso, DO, PhD(H)
Yale University School of Medicine, Yale Cancer Center
New Haven, Connecticut, United States
Robert G. Maki, MD, PhD (he/him/his)
Member & Professor of Medicine
Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
New York, New York, United States
Robin L. Jones, BSc, MB BS, MRCP, MD
Professor
Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
London, England, United Kingdom
Jean-Yves Blay, MD, PhD
Centre Léon Bérard
Lyon, Rhone-Alpes, France
Alannah Smrke, MD, FRCPC
BC Canada
Vancouver, British Columbia, Canada
Albiruni Abdul Razak, MB BCh, BAO, LRCP & SI
Toronto Sarcoma Program, Princess Margaret Cancer Center
Toronto, Ontario, Canada
Antoine Italiano, MD, PhD
Institut Bergonié
Bordeaux, Aquitaine, France
Ana Sebio, MD, PhD
Consultant Medical Oncologist
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
Rastislav Bahleda, MD
Institut Gustave Roussy
Villejuif, Ile-de-France, France
Yeh Chen Lee, MD (she/her/hers)
Medical Oncologist
Prince of Wales Hospital
Randwick, New South Wales, Australia
Winette van der Graaf, MD, PhD
Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center
Amsterdam, Zuid-Holland, Netherlands
Xing Zhang, MD, PHD
Professor
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China (People's Republic)
Medhi Lahmar, MD, PhD
Boehringer Ingelheim International GmbH
Ingelheim am Rhein, Rheinland-Pfalz, Germany
Michael Teufel, PhD (he/him/his)
Executive Director
Boehringer Ingelheim Pharmaceuticals Inc.
Ridgefield, Connecticut, United States
Andrew J. Wagner, MD, PhD
MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
